Previous close | 44.00 |
Open | N/A |
Bid | 60.20 |
Ask | 70.00 |
Strike | 1,110.00 |
Expiry date | 2024-12-20 |
Day's range | 44.00 - 44.00 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 0% and 4.92%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Mettler-Toledo's (MTD) first-quarter performance is likely to reflect the adverse impacts of macroeconomic headwinds, and weak momentum across the Industrial and Laboratory segments.
Beyond analysts' top -and-bottom-line estimates for Mettler-Toledo (MTD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.